Evolus, Inc. (NASDAQ:EOLS) will be hosting a conference call at 4:30 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.evolus.com
Earnings Expectation
Evolus, Inc. is set to announce second quarter earning results on Monday 10th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, EOLS to report 2Q20 loss of $ 0.7 per share. For the full year, analysts anticipate top line of $ 38.81 million, while looking forward to loss of $ 2.26 per share bottom line.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was founded in 2012 and is headquartered in Newport Beach, California.
